PPB - Services

Complaints, Feedback and Enquiry

Medicine Quality Alert: Class I Medicines Recall of Blink Injection (Paracetamol 1% w/v)

The Pharmacy and Poisons Board has mandated Crown Healthcare Limited to initiate an urgent recall of batches CM4594005 and CM4594004 of Blink Injection (Paracetamol 1%w/v).

From: Pharmacy and Poisons Board

Date of Recall Initiation: 24th April 2025

Recall Reference Number: REC/2025/014

Recall Classification: Class I

Recall Level: Consumer-level

Manufacturer: KamlaAmrut Pharmaceutical LLP, India

Local Technical Representative: Crown Healthcare Limited

Product name: Blink Injection

Active Pharmaceutical Ingredient: Paracetamol 1g/100ml

Affected counties: All

Affected batch

Batch Number

Date of Manufacture

Date of expiry

Pack Size

CS4594005

09/2024

08/2026

100 ml

CS4594004

09/2024

08/2026

100 ml

Brief description of the problem

The Pharmacy and Poisons Board has mandated Crown Healthcare Limited to initiate an urgent recall of Blink Injection (Paracetamol 1%w/v) batches CM4594005 and CM4594004 following market complaints of color change of the product to black.

Action for healthcare professionals

Quarantine all remaining stock and stop further distribution, sale, issuing, or use of the above batches immediately. Await contact from the Crown Healthcare Limited team to arrange the return.

Action for patients and caregivers

No further action is required by patients as this product is usually administered by healthcare professionals in a hospital setting, and the recall is a Retail/Hospital Pharmacy and Wholesaler/Distributor level recall.

Further Information

For any inquiries on the consignments, please contact Crown Healthcare Limited, P.O. Box 40449-00100 Nairobi. Kenya, by email at rahab.njuguna@crownkenya.com or via telephone at +254 721 200 400 or +254 733 200 400

Promptly report any case/s of suspected substandard and falsified product or adverse reactions or insufficient control of symptoms to the nearest healthcare facility or the Pharmacy and Poisons Board through the following channels:

For any further inquiries and feedback on the product recall, kindly contact the post-marketing surveillance unit of the Pharmacy and Poisons Board Kenya “the Board” via email at pms@ppb.go.ke

Download document

Medicine Quality Alert: Class I Medicines Recall of Blink Injection (Paracetamol 1% w/v)